Skip to content

SANIMED: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SANIMED

BE 0448.804.548
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€28,974
2024 · €8,296+€20,678
Equity
€619,306
2024 · €590,333+€28,974
Cash
€8,668
2024 · €9,564-€895
Balance sheet total
€786,238
2024 · €770,321+€15,917

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€40,751

    up €40,751 (+10.0%), from €408,359 to €449,110

    of which Other amounts receivable: +€35,470

  • Tangible fixed assets -€21,994

    down €21,994 (-10.3%), from €212,685 to €190,691

    of which Plant, machinery and equipment: -€15,455

Equity and liabilities
  • Reserves +€28,974

    up €28,974 (+5.1%), from €571,733 to €600,706

  • Trade debts -€11,843

    down €11,843 (-7.8%), from €151,518 to €139,675

Income statement
  • Gross operating margin +€24,040

    up €24,040 (+8.9%), from €271,306 to €295,346

  • Taxes +€6,803

    up €6,803 (+140.9%), from €4,828 to €11,631

  • Staff costs -€5,151

    down €5,151 (-2.2%), from €235,823 to €230,672

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €8,296
Gross operating margin +€24,040
Staff costs +€5,151
Depreciation -€1,494
Other operating charges +€272
Financial income -€402
Financial charges -€86
Taxes -€6,803
Result 2025 €28,974

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€7,075
Investment -€7,971
Financing €0
Cash 2024 €9,564
Net result for the year +€28,974
Depreciation +€29,965
Stocks and contracts +€1,944
Receivables within one year -€40,751
Trade debts -€11,843
Tax, wage and social debts -€1,214
Investment in fixed assets (net) -€7,971
Cash 2025 €8,668
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €770,321 €786,238 +€15,917 +2.1%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €212,685 €190,691 -€21,994 -10.3%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €212,685 €190,691 -€21,994 -10.3%
Land and buildings 22 €69,033 €61,584 -€7,449 -10.8%
Plant, machinery and equipment 23 €137,950 €122,495 -€15,455 -11.2%
Furniture and vehicles 24 €5,702 €6,611 +€910 +16.0%
Current assets 29/58 €557,636 €595,548 +€37,912 +6.8%
Stocks and contracts in progress 3 €139,714 €137,770 -€1,944 -1.4%
Stocks 30/36 €139,714 €137,770 -€1,944 -1.4%
Amounts receivable within one year 40/41 €408,359 €449,110 +€40,751 +10.0%
Trade receivables 40 €116,941 €122,223 +€5,281 +4.5%
Other amounts receivable 41 €291,417 €326,887 +€35,470 +12.2%
Cash at bank and in hand 54/58 €9,564 €8,668 -€895 -9.4%
Total equity and liabilities 10/49 €770,321 €786,238 +€15,917 +2.1%
Equity 10/15 €590,333 €619,306 +€28,974 +4.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €571,733 €600,706 +€28,974 +5.1%
Distributable reserves 133 €571,733 €600,706 +€28,974 +5.1%
Amounts payable 17/49 €179,988 €166,932 -€13,056 -7.3%
Amounts payable within one year 42/48 €179,988 €166,932 -€13,056 -7.3%
Trade debts 44 €151,518 €139,675 -€11,843 -7.8%
Suppliers 440/4 €151,518 €139,675 -€11,843 -7.8%
Taxes, remuneration and social security 45 €28,470 €27,257 -€1,214 -4.3%
Taxes 450/3 - €1,631 +€1,631
Remuneration and social security 454/9 €28,470 €25,626 -€2,845 -10.0%
Non-recurring operating income 76A €3,157 - -€3,157
Remuneration, social security and pensions 62 €235,823 €230,672 -€5,151 -2.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €28,471 €29,965 +€1,494 +5.2%
Other operating charges 640/8 €2,838 €2,567 -€272 -9.6%
Gross operating margin 9900 €271,306 €295,346 +€24,040 +8.9%
Operating profit (loss) 9901 €4,174 €32,142 +€27,969 +670.1%
Financial income 75/76B €9,387 €8,985 -€402 -4.3%
Recurring financial income 75 €9,387 €8,985 -€402 -4.3%
Financial charges 65/66B €437 €523 +€86 +19.7%
Recurring financial charges 65 €437 €523 +€86 +19.7%
Profit (loss) for the period before taxes 9903 €13,124 €40,605 +€27,481 +209.4%
Income taxes 67/77 €4,828 €11,631 +€6,803 +140.9%
Profit (loss) for the period 9904 €8,296 €28,974 +€20,678 +249.3%
Profit (loss) for the period to be appropriated 9905 €8,296 €28,974 +€20,678 +249.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.